A290660 Stock Overview
Researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Neofect Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩896.00 |
| 52 Week High | ₩1,580.00 |
| 52 Week Low | ₩671.00 |
| Beta | 0.77 |
| 1 Month Change | 1.93% |
| 3 Month Change | -2.08% |
| 1 Year Change | -27.92% |
| 3 Year Change | -71.42% |
| 5 Year Change | -83.22% |
| Change since IPO | -88.36% |
Recent News & Updates
Investor Optimism Abounds Neofect Co., Ltd. (KOSDAQ:290660) But Growth Is Lacking
Dec 04
There Is A Reason Neofect Co.,Ltd's (KOSDAQ:290660) Price Is Undemanding
Jun 19Shareholder Returns
| A290660 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 1.6% | -3.7% | -1.9% |
| 1Y | -27.9% | -4.3% | -9.5% |
Return vs Industry: A290660 underperformed the KR Medical Equipment industry which returned -4.3% over the past year.
Return vs Market: A290660 underperformed the KR Market which returned -9.5% over the past year.
Price Volatility
| A290660 volatility | |
|---|---|
| A290660 Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A290660 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A290660's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 49 | Ho-young Ban | www.neofect.com |
Neofect Co., Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to promote improved functional reach and muscle control; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect Smart Table for dementia prevention and rehabilitation program; Neomano, a wearable robotic glove; Neofect Comcog, a cognitive rehabilitation program that helps patients with stroke, dementia, traumatic brain injury, brain tumor, and cerebral palsy; and Neofect TeleRehab, a teletherapy platform designed for remote rehabilitation, as well as a range of orthotic and assistive devices.
Neofect Co., Ltd. Fundamentals Summary
| A290660 fundamental statistics | |
|---|---|
| Market cap | ₩41.22b |
| Earnings (TTM) | -₩3.96b |
| Revenue (TTM) | ₩21.12b |
2.0x
P/S Ratio-10.4x
P/E RatioIs A290660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A290660 income statement (TTM) | |
|---|---|
| Revenue | ₩21.12b |
| Cost of Revenue | ₩11.63b |
| Gross Profit | ₩9.49b |
| Other Expenses | ₩13.45b |
| Earnings | -₩3.96b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -86.05 |
| Gross Margin | 44.95% |
| Net Profit Margin | -18.74% |
| Debt/Equity Ratio | 65.6% |
How did A290660 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 18:38 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Neofect Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Seung Kyu Jung | Kiwoom Securities Co., Ltd. |